Counseling breast cancer patients on contralateral prophylactic mastectomy: The physician's role

ONCOLOGY

Volumn 22, Issue 5, 2008, Pages 545-548

  Tuttle, Todd M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; PLACEBO; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL TRIAL; CONTRALATERAL PROPHYLACTIC MASTECTOMY; GENE MUTATION; HUMAN; MASTECTOMY; MONOTHERAPY; PATIENT COUNSELING; PATIENT DECISION MAKING; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; RECURRENCE RISK; SEROMA; TUMOR SUPPRESSOR GENE; BREAST TUMOR; COUNSELING; FEMALE; GENETICS; PATHOLOGY;

BREAST NEOPLASMS; COUNSELING; FEMALE; HUMANS; MASTECTOMY; PATIENT SATISFACTION; PHYSICIAN'S ROLE; POSTOPERATIVE COMPLICATIONS;

EID: 50949117548     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tuttle TM, Habermann EB, Grund EH, et al: Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment. J Clin Oncol 25:5203-5209, 2007.
2. Robbins GF, Berg JW: Bilateral primary breast cancer; a prospective clinicopathological study. Cancer 17:1501-1527, 1964.
3. Storm HH, Jensen OM: Risk of contralateral breast cancer in Denmark 1943-80. Br J Cancer 54:483-492, 1986.
4. Prior P, Waterhouse JA: The incidence of bilateral breast cancer: II. A proposed model for the analysis of coincidental tumours. Br J Cancer 43:615-622, 1981.
5. Adami HO, Bergstrom R, Hansen J: Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study. Cancer 55:643-647, 1985.
6. Gao X, Fisher SG, Emami B: Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: A population-based study. Int J Radiat Oncol Biol Phys 56:1038-1045, 2003.
7. Fung MC, Schultz DJ, Solin LJ: Early-stage bilateral breast cancer treated with breast-conserving surgery and definitive irradiation: The University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 38:959-967, 1997.
8. Gogas J, Markopoulos C, Skandalakis P, et al: Bilateral breast cancer. Am Surg 59:733-735, 1993.
9. Ford D, Easton DF, Stratton M, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676-689, 1998.
10. Verhoog LC, Brekelmans CT, Seynaeve C, et al: Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 351:316-321, 1998.
11. Wolden SL, Hancock SL, Carlson RW, et al: J Clin Oncol 18:765-772, 2000.
12. Erdreich LS, Asal NR, Hoge AF: Morphologic types of breast cancer: Age, bilaterality, and family history. South Med J 73:28-32, 1980.
13. Peralta EA, Ellenhorn JD, Wagman LD, et al: Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg 180:439-445, 2000.
14. McDonnell SK, Schaid DJ, Myers JL, et al: Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 19:3938-3943, 2001.
15. Herrinton LJ, Barlow WE, Yu O, et al: Efficacy of prophylactic mastectomy in women with unilateral breast cancer: A cancer research network project. J Clin Oncol 23:4275-4286, 2005.
16. van Sprundel TC, Schmidt MK, Rookus MA, et al: Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer 93:287-292, 2005.
17. Goldflam K, Hunt KK, Gershenwald JE, et al: Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer 101:1977-1986, 2004.
18. Lostumbo L, Carbine N, Wallace J, et al: Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev (4): CD002748, 2004.
19. Schrag D, Kuntz KM, Garber JE, et al: Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA 283:617-624, 2000.
20. Barton MB, West CN, Liu IL, et al: Complications following bilateral prophylactic mastectomy. J Natl Cancer Inst Monogr 35:61-66, 2005.
21. Sacchini V, Pinotti JA, Barros AC, et al: Nipple-sparing mastectomy for breast cancer and risk reduction: Oncologic or technical problem? J Am Coll Surg 203:704-714, 2006.
22. Simmons RM, Brennan M, Christos P, et al: Analysis of nipple/areolar involvement with mastectomy: Can the areola be preserved? Ann Surg Oncol 9:165-168, 2002.
23. Ciatto S, Ambrogetti D, Bonardi R, et al: Prognostic impact of early detection of contralateral primary breast cancer. Tumori 76:370-373, 1990.
24. Mellink WA, Holland R, Hendriks JH, et al: The contribution of routine follow-up mammography to an early detection of asynchronous contralateral breast cancer. Cancer 67:1844-1848, 1991.
25. Burns PE, Dabbs K, May C, et al: Bilateral breast cancer in northern Alberta: Risk factors and survival patterns. Can Med Assoc J 130:881-886, 1984.
26. Fisher B, Redmond C: New perspective on cancer of the contralateral breast: A marker for assessing tamoxifen as a preventive agent. J Natl Cancer Inst 83:1278-1280, 1991.
27. Stewart HJ: The Scottish trial of adjuvant tamoxifen in node-negative breast cancer. Scottish Cancer Trials Breast Group. J Natl Cancer Inst Monogr 11:117-120, 1992.
28. Rutqvist LE, Cedermark B, Glas U, et al: Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy. J Natl Cancer Inst 83:1299-1306, 1991.
29. Baum M, Budzar AU, Cuzick J, et al: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial. Lancet 359:2131-2139, 2002.
30. Frost MH, Slezak JM, Tran NV, et al: Satisfaction after contralateral prophylactic mastectomy: The significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol 23:7849-7856, 2005.
31. Montgomery LL, Tran KN, Heelan MC, et al: Issues of regret in Women with contralateral prophylactic mastectomies. Ann Surg Oncol 6:546-552, 1999.
32. Geiger AM, West CN, Nekhlyudov L, et al: Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol 24:1350-1356, 2006.
33. Schwartz MD, Lerman C, Brogan B, et al: Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol 22:1823-1829, 2004.